Skip to content
PPD Inc
Main Menu
  • Blog
  • Careers
  • Contact Us
  • Investors
  • News
  • Japan
Search
  • Who We Are
    • Our Mission
      • Accolades
      • Company History
    • Our 4i Values
    • Our Work
      • Our Solutions
      • How We Help
      • Therapeutic Areas
    • Corporate Responsibility
      • Environmental Stewardship
      • Health and Wellness
      • Philanthropy
      • PPD Heroes
    • Locations
    • Company Resources
      • Ethics
      • Events
      • Investors
      • PPD in the News
      • Legal Notices
      • Privacy Policy
      • Vendor Resources
  • How We Help
    • Building Patient-Driven Trials
    • Clinical Trial Certainty/Reliability
    • COVID-19
      • Resources
    • Decentralized Clinical Trials
      • Choosing DCTs
      • DCT Capabilities and Solutions
      • DCT Therapeutic Expertise
      • Why PPD DCT
      • Resources
    • Expertise in Asia-Pacific
      • PPD in China
      • PPD-SNBL in Japan
    • Industry Trends
    • Navigating Pivotal Moments
      • Stability
      • Agility
      • Ingenuity
    • PPD Biotech
    • Functional Service Partnership Solutions
  • Our Customers
    • Consumer Health
    • PPD Biotech
    • Government and Public Health
    • Medical Device Development
  • Our Solutions
    • Clinical Development
      • Early Development
        • EDS Global Capabilities
        • Phase I
      • Phase II-IV Clinical Trial Management
        • Biostatistics
        • Clinical Data Management
        • Clinical Trial Monitoring
        • Clinical Trial Project Management
        • Global Clinical Supplies
        • Medical Writing
        • Pharmacokinetic and Pharmacodynamic
        • Pharmacovigilance
      • Peri- and Post-approval
        • Data and Real-World Evidence
        • Evidence Synthesis, Modeling and Communication
        • Interventional Studies
        • Medical Communications
        • Non-Interventional Studies
        • Pharmacovigilance
      • PPD Biotech
      • PPD Functional Service Partnership Solutions
        • PPD FSP Source
        • FSP Resources
      • Product Development and Consulting
      • Quality and Enterprise Learning
      • Regulatory Affairs
      • Site and Patient Centric Solutions
        • Accelerated Enrollment Solutions (AES)
        • Enrollment and Site Activation
        • Integrating the Patient Voice
        • Leveraging Technology
        • Reducing Patient Burden
      • Technology
        • Decentralized Clinical Trials
        • FSP Source
        • Information Security
        • Preclarus
        • Support Systems and Services
    • PPD Laboratory Services
      • Bioanalytical Lab
        • Bioanalytical Lab Capabilities
        • Bioanalytical Lab Experience and Expertise
        • PPD® Laboratories Tech Talks
        • Bioanalytical Lab Resources
      • Biomarker Lab
        • Biomarker Lab Capabilities
        • Biomarker Lab Resources
      • Central Lab
        • Central Lab Capabilities
        • Certifications
        • Preclarus Lab Solutions
        • Central Lab Resources
      • GMP Lab
        • GMP Lab Capabilities
        • GMP Lab Experience and Expertise
        • Athlone Lab
        • GMP Lab Resources
      • Vaccine Sciences Lab
        • Vaccine Sciences Lab Capabilities
        • Vaccine Sciences Lab Resources
      • PPD Laboratories FSP
      • Part of the COVID-19 Solution
  • Therapeutic Areas
    • Biosimilar Development
    • Cardiovascular
    • Cell and Gene Therapy
    • Critical Care
    • Dermatology
    • Gastroenterology
    • Immunology and Rheumatology
    • Infectious Diseases
    • Metabolic and Endocrine
      • Diabetes
      • Rare metabolic disease
    • Nephrology and Renal Diseases
    • Neuroscience Research
      • Neurodegenerative Disorders
      • Rare Neurological Disorders
      • Psychiatry
      • Neuroinflammatory and Other Disorders
    • Oncology and Hematology
    • Ophthalmology
    • Pediatrics
    • Rare Diseases
    • Respiratory
    • Urology
    • Vaccine Development
    • Women’s Health
  • Participate in a Trial
    • Austin Clinical Research Unit
      • Volunteer Opportunities
      • Who can be a volunteer
      • What to Expect
      • Online Tour
      • Study Volunteer FAQ
      • Contact Information
    • Las Vegas Clinical Research Unit
      • Volunteer Opportunities
      • Who can be a volunteer
      • What to Expect
      • Online Tour
      • Study Volunteer FAQ
      • Contact Information
    • Orlando Clinical Research Unit
    • Phase II-IIIb Clinical Trial Volunteers
    • Become a Clinical Trial Investigator
      • Advantages of Being a Clinical Trial Investigator
      • FAQ
      • SiteCoach
      • Process
      • Informed Consent
      • IRB
      • Clinical Trial Investigators Database Registration
hex

Monoclonal Antibody (mAb) Therapeutics, Here to Stay?

Our SolutionsPPD Laboratory ServicesBioanalytical LabBioA Experience and ExpertiseBioanalytical Lab Thought Leadership SeriesMonoclonal Antibody (mAb) Therapeutics, Here to Stay?

Megan Wiberg, of our bioanalytical lab, discusses the future of monoclonal antibody therapeutics in the evolving bioanalytical industry.

Watch the video below.

  • Legal Notices
  • Site Map
  • Modern Slavery Transparency Statement
  • Privacy Policy
©2022 PPD Inc. All Rights Reserved.
  • Contact Us
  • LinkedIn
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • Events